North American Pediatric Renal Transplantation Study (NAPRTCS) Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
1998
NCT00005009
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now

Alternative names

North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

Active Ingredients

Drugs in Phase 1 Trials (1)

live attenuated varicella vaccine (Varivax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Zoster (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1